Joann Pinkerton is an Obstetrics and Gynecologist in Charlottesville, Virginia. Dr. Pinkerton is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Postmenopausal Osteoporosis, Premature Ovarian Failure, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Pinkerton is currently accepting new patients.

Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.

Joann Manson is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Manson is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Type 2 Diabetes (T2D), Coronary Heart Disease, Hormone Replacement Therapy (HRT), and Tubal Ligation.

Andrew Kaunitz is an Obstetrics and Gynecologist in Jacksonville, Florida. Dr. Kaunitz is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Menopause, Menorrhagia, Newborn Low Blood Sugar, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Kaunitz is currently accepting new patients.

Anne Gompel practices in Paris, France. Ms. Gompel is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Angioedema, Hereditary Angioedema, Hives, and Hormone Replacement Therapy (HRT).

David Bierer is an Obstetrics and Gynecologist in South Ogden, Utah. Dr. Bierer is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Menopause, Menorrhagia, Premenstrual Syndrome, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Bierer is currently accepting new patients.

Andrew Berchuck is a Gynecologic Oncologist in Durham, North Carolina. Dr. Berchuck is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Tubal Ligation, and Oophorectomy. Dr. Berchuck is currently accepting new patients.

Farid Saad practices in Leverkusen, Germany. Mr. Saad is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Metabolic Syndrome, Obesity, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Abraham Morgentaler is an Urologist in Chestnut Hill, Massachusetts. Dr. Morgentaler is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Hypogonadotropic Hypogonadism, Hormone Replacement Therapy (HRT), and Orchiectomy. Dr. Morgentaler is currently accepting new patients.

Ranjith Ramasamy is an Urologist in Miami, Florida. Dr. Ramasamy is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Testicular Failure, Hypogonadism, Erectile Dysfunction (ED), Vasectomy, and Hormone Replacement Therapy (HRT).

Ahmad Haider practices in Bremerhaven, Germany. Mr. Haider is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Type 2 Diabetes (T2D), Obesity, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Karim Haider practices in Bremerhaven, Germany. Mr. Haider is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Type 2 Diabetes (T2D), Isolated Hypogonadotropic Hypogonadism, Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Emmanuel Antonarakis is an Oncologist in Minneapolis, Minnesota. Dr. Antonarakis is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Antonarakis is currently accepting new patients.

Mohit Khera is an Urologist in Houston, Texas. Dr. Khera is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Peyronie Disease, Erectile Dysfunction (ED), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Khera is currently accepting new patients.

Larry Lipshultz is an Urologist in Houston, Texas. Dr. Lipshultz is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Peyronie Disease, Hypogonadism, Infertility, Vasectomy, and Hormone Replacement Therapy (HRT). Dr. Lipshultz is currently accepting new patients.

Jesse Ory is an Urologist in Coral Gables, Florida. Dr. Ory is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Varicocele, Hypogonadism, Erectile Dysfunction (ED), Hormone Replacement Therapy (HRT), and Vasectomy.

Taylor Kohn is an Urologist in Houston, Texas. Dr. Kohn is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Erectile Dysfunction (ED), Partial Deletion of Y, Peyronie Disease, Hormone Replacement Therapy (HRT), and Vasectomy.

Claus Gravholt practices in Arhus, Denmark. Mr. Gravholt is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Turner Syndrome, Intersex, Klinefelter Syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy.